LMP1 and LMP2 may be prognostic factors for outcome of therapy in nasopharyngeal cancers in Indonesia

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 3, 2010, Pages 763-766

  Hariwiyanto, Bambang ^a   Sastrowiyoto, Sunarto ^a   Mubarika, Sofia ^a   Salugu, Maesadji ^b  

^a Sardjito Hospital   (Indonesia)

^b GADJAH MADA UNIVERSITY   (Indonesia)

Author keywords

Indonesia; LMP1; LMP2; NPC; Prognosis factors

Indexed keywords

EID: 78650684724     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Allen MD, Young LS, Dawson CW (2005). The Epstein-Barr Encoded LMP2A and LMP2B Proteins Promote Epthelial Cell Spreading and Motility. J Virol, 79, 1789-802.
2. Brooks L, Thomas JA (1995). The significance of Epstein Barr virus in the pathogenesis of lymphoid and epithelial neoplasma. Current Diagnosstic Pathology, 2, 127-98.
3. Edwards RH, Sitki-green D, Moore DT, et al (2004). Potential Selection of LMP1 Variants in Nasopharyngeal Carcinoma. J Virol, 78, 868-81.
4. Horikawa T, Yoshuzaki T, Sheen T, et al (2000). Association of Latent Membrane Protein 1 and Matrix Metalloproteinase 9 wirh Metastasis in Nasopharyngeal Cancer. Cancer, 89, 715-23.
5. Khabir A, Karray H, Rodriques S, et al (2005). EBV Latent membrane Protein 1 abundance correlates with patient age but NOt with metastastic behaviour in NOrth African nasopharyngeal carcinomas. Virol J, 2, 39.
6. Khanna R, Burrows SR, Moss DJ (1995). Immune Regulation in Epstein Barr Virus Associated Disease. Microbiologycal Review, 387-405.
7. Li A, Dubey S, Varney ML, et al (2003). IL-8 Directly Enhanched Cell Survival, Proliferastion and Matrix Metalloproteinases Production and Regulated Angiogenesis. J Immunol, 170, 3369-76.
8. Ma J, Liu L, Tang l, et al (2007). Retropharyngeal Lymphnode Metastasis in Nasopharyngeal Carcinoma: Prognostic and Staging Categories. Clin Cancer Res, 13.
9. Middeldorp JM, Brink AA, van den Brule AJ, et al (2003). Pathogenic role for Epstein-Barr virus gene products in EBV-assosiated proliferative disorders. Clin Rev Oncology Hematol, 45, 1-36.
10. Murono S, Inoue H, Tanabe T, et al (2001). Induction of Cyclooxygenase 2 by Epstein Barr Virus latent Membrane Protein 1 is Involved In Vascular Endothelial Growth Factor production In Nasopharyngeal Carcinoma Cell. Proc Natl Acad Sci U S A, 98, 6905-10.
11. Patmanathan R (1998). Can NPC be Prevented. UICC Workshop On Nasopharyngeal Cancer. Issue and Challenge, Singapore cancer Society, 56-7.
12. Pegtel DM, Subramanian A, Sheen TS, et al (2005). Epstein-Barr Virus Encoded LMP2A Induces Primary Epithelial Cell Migration and Invasion: Possible Role in Nasopharyngeal Carcinoma Metastasis. J Virol, 79, 1540-42.
13. Tang L, Li l, Mao Y, et al (2008). Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma detected by magnetic resonance imaging: prognostic value and staging categories. Pubmed result. Cancer.
14. Uzzo RB, Cairns P, Dulin N, et al (2005). Tumor resistance to Aapoptosis. In Finke JH, Bukowski M. Editors. 'Cancer Immunotherapy at the Crossroads', Humana Press Inc., 215-27.
15. Wakisaka N, Kondo S, Yoshizaki T, et al (2004). Epstein-Barr Virus Latent Membrane Protein 1 Induces Synthesis of Inducible Factor 1α. Mol Cell Biol, 24, 5223-34.
16. Yoshizaki T, Wakisaka N, Pagano JS (2005). Epstein-Barr Virus and Metastasis. In. Robertson ES. Editor. 'Epstein-Barr Virus', Caister Academic Press.
17. Zetterberg H, Rymo L (2005). EBNA2 Transcription Regulation in EBV Latency. In Robertson EE. Editor. 'Epstein-Barr Virus', Caister Academic Press.